PharmaCyte Biotech Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PMCB
PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate is referred to as CypCaps. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used to produce various biologically active molecules. It is advancing clinical research and development of new cellular-based therapies in oncology and diabetes. It is also focused on developing therapies for pancreatic and other solid cancerous tumors by using genetically engineered live human cells. Its product candidate for the treatment of diabetes consists of encapsulated genetically modified insulin-producing cells. It is also focused on the benefits of the Cell-in-a-Box technology to develop therapies for cancer that involve prodrugs based upon certain constituents of the Cannabis plant.
Find out what a historical investment in PharmaCyte Biotech Inc would be worth today using our PMCB stock calculator.
$7.69M
-
0.00%
16.8K
$1.16
$1.08
$1.16
$2.42
$1.03
Ready to start your investing journey with Stake?
Open an accountPMCB FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PMCB
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PMCB
on Stake
Buy PMCB from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PMCB from only US$10 with fractional shares
